Alyeska Investment Group’s Elanco Animal Health ELAN Stock Holding History

Alyeska Investment Group’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.9M	Buy	+1,498,380	New	+$34.6M	0.09%	250
2025 Q1	–	Sell	-900,000	Closed	-$10.9M	–	552
2024 Q4	$10.9M	Sell	900,000 -1,623,687	-64%	-$21.2M	0.04%	329
2024 Q3	$37.1M	Buy	2,523,687 +1,195,021	+90%	+$16.7M	0.19%	166
2024 Q2	$19.2M	Buy	1,328,666 +103,062	+8%	+$1.65M	0.11%	215
2024 Q1	$20M	Buy	+1,225,604	New	+$19.2M	0.12%	215
2020 Q4	–	Sell	-239,779	Closed	-$6.7M	–	534
2020 Q3	$6.7M	Sell	239,779 -66,016	-22%	-$1.67M	0.1%	228
2020 Q2	$6.56M	Sell	305,795 -1,680,350	-85%	-$37.1M	0.1%	240
2020 Q1	$44.5M	Buy	1,986,145 +694,927	+54%	+$19M	0.89%	33
2019 Q4	$38M	Buy	1,291,218 +1,274,706	+7,720%	+$34.6M	0.5%	71
2019 Q3	$439K	Buy	+16,512	New	+$495K	0.01%	367
2019 Q1	–	Sell	-125,000	Closed	-$3.94M	–	401
2018 Q4	$3.94M	Sell	125,000 -275,000	-69%	-$9M	0.06%	244
2018 Q3	$14M	Buy	+400,000	New	+$14.1M	0.15%	156

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Alyeska Investment Group's ELAN Position: Q2 2026 in Review

Alyeska Investment Group opened a new position in Elanco Animal Health (ELAN) in Q2 2026: 1,498,380 shares worth $36.9M. The stake represents 0.09% of the portfolio and ranks #250 among its holdings. This is a return to the name: Alyeska Investment Group previously reported a position in ELAN as recently as Q4 2024.

Alyeska Investment Group first reported a position in ELAN in Q3 2018 and has held it in 12 quarters since. The position peaked at $44.5M in Q1 2020. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Alyeska Investment Group held 1,498,380 shares of Elanco Animal Health worth $36.9M as of Q2 2026.
Elanco Animal Health was a new Alyeska Investment Group position in Q2 2026.
Elanco Animal Health made up 0.09% of Alyeska Investment Group's portfolio in Q2 2026, its #250 holding.
Alyeska Investment Group first reported a position in Elanco Animal Health in Q3 2018 and has held it in 12 quarters since.
Alyeska Investment Group's Elanco Animal Health position peaked at $44.5M in Q1 2020.
523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.